Description
Chromium picolinate is clinically used to decrease fasting blood glucose and insulin levels. Chromium picolinate exhibits anti-hyperlipidemic, cardioprotective, and anti-diabetic activities. In high-fat diet-fed rats, chromium picolinate decreases plasma lipid levels and platelet aggregation. In spontaneously hypertensive rats, this compound improves myocardial contractility, myocardial relaxation, and coronary blood flow after cardiac ischemia/reperfusion.